CMS Open Payments · Program Year 2024
Talis Clinical LLC
Talis Clinical LLC reported $150,875.08 across General Payments, Research, and Ownership to 23 physicians and teaching hospitals across 23 transactions.
- $150.9K
- All-tracks total
- 23
- Transactions
- 23
- Recipients
- #1080
- of 1,925 companies
Talis Clinical LLC reported $150,875.08 across all CMS Open Payments tracks (General + Research + Ownership) to 23 physicians and teaching hospitals in Program Year 2024 - ranking #1080 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $150,875.08, averaging $6.6K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer talis-clinical-llc Talis Clinical LLC
$150.9K · #1080/1,925 · 0.0% industry · PY2024
- TOT $150.9K
- RANK #1080
- SHARE 0.0%
- TXN 23
- RCP 23
- CAT 2
- GEN $150.9K
- TOP1 99.4%
- PY 2024
Volume peers
Nearest volume peer: Asahi Intecc Co., Ltd. ($150.9K)
Talis Clinical LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Talis Clinical LLC
Rank #1080 of 1,925 companies in CMS Open Payments for 2024 belongs to Talis Clinical LLC, which reported $150,875.08 across 23 transactions to 23 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $6.6K per transaction and $6.6K per recipient.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $150.0K, accounting for 99.4% of this company's General Payments and 1 transactions.
General Payment Breakdown by Type
Talis Clinical LLC made 2 types of general payments. "Royalty or License" is the largest category at $150.0K, 99.4% of General Payments.
How Talis Clinical LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $150.0K | 1 | 99.4% |
| Food and Beverage | $875.08 | 22 | 0.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $150,522.89 (99.8%) of $150,875.08 in this company's General Payments records across 16 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Talis Clinical LLC
The five named recipients with the highest reported General Payments from this company
- 1
Cleveland Clinic Hospital
$150,000.00 across 1 reported transactions
- 2
Michael Sasevich
$212.46 across 4 reported transactions
- 3
Dan Berkowitz
$114.56 across 1 reported transactions
- 4
Melissa Mendoza Suyo
$108.61 across 2 reported transactions
- 5
Manuel Lee
$87.26 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Talis Clinical LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Talis Clinical LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Talis Clinical LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Iridex Corporation
One Lambda, Inc.
Arjo Inc.
Volpara Health, Inc
Cgg Medical Inc
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.